BRIEF-Celgene says net pre-tax charge to Q4 earnings estimated to be $300 mln to $500 mln
October 19, 2017 at 17:36 PM EDT
* Celgene - concluded oct 18 will recognize q4 charge to earnings related to impairment of about $1,600 million ged-0301 IPR&D asset - sec filing
